Metastatic Renal Cell Carcinoma Withdrawn Phase 1 Trials for Cyclophosphamide (DB00531)

Also known as: Metastatic Renal cell carcinoma

IndicationStatusPhase
DBCOND0030098 (Metastatic Renal Cell Carcinoma)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02867332PD-1 Knockout Engineered T Cells for Metastatic Renal Cell Carcinoma.Treatment